Stay updated on Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record no longer lists the 2016 NIH grant/contract identifier, and the site revision advances from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T19:43:26.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The Morpheus-Pancreatic Cancer study record is displayed with details on its treatment combinations, eligibility, locations, and measured outcomes. It is marked completed and no longer recruiting, with results and a study protocol document available.
    Difference
    98%
    Check dated 2026-11-08T01:34:19.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T20:27:32.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    1%
    Check dated 2026-10-24T22:15:56.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:00:40.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T21:53:05.000Z thumbnail image

Stay in the know with updates to Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.